[Anticytokine therapy in the treatment of patients with chronic heart failure]

MeSH terms

• Animals
• Anti-Inflammatory Agents / administration & dosage
• Anti-Inflammatory Agents / therapeutic use
• Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / therapeutic use
• Chronic Disease
• Clinical Trials as Topic
• Cytokines / antagonists & inhibitors*
• Disease Models, Animal
• Etanercept
• Heart Failure / diagnosis
• Heart Failure / drug therapy
• Heart Failure / epidemiology
• Heart Failure / immunology
• Heart Failure / mortality
• Heart Failure / therapy*
• Humans
• Immunoglobulin G / administration & dosage
• Immunoglobulin G / therapeutic use
• Immunoglobulins / therapeutic use
• Infliximab
• Mice
• Placebos
• Prognosis
• Receptors, Tumor Necrosis Factor / administration & dosage
• Receptors, Tumor Necrosis Factor / therapeutic use
• Recombinant Fusion Proteins / therapeutic use
• Time Factors
• Tumor Necrosis Factor-alpha / administration & dosage
• Tumor Necrosis Factor-alpha / therapeutic use